Has Doris Hansen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $141,343 in general payments to Doris Hansen, MD across 105 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Doris Hansen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Doris Hansen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Doris Hansen, MD

Hematology · Tampa, FLNPI 1881958270

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $97,401 of the $141,343 with a category attached, or 68.9%. 17 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 26.2% of the total. 2025 is the largest year on record at $62,266, more than ten times the $469 reported in 2019. Among hematology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$141,343in general payments, 2019–2025

Across 105 payments — averaging $1346.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$37K
Janssen Scientific Affairs, LLC$26K
Johnson & Johnson$20K
Legend Biotech USA Inc.$20K
Bristol Myers Squibb$16K
AstraZeneca$5K
plus $17K from 11 others

$1,687,308in research payments, 2019–2025

Across 24 payments — averaging $70,305 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Janssen Scientific Affairs, LLC$777K
Bristol Myers Squibb$544K
E.r. Squibb & Sons, L.L.C.$297K
Adaptive Biotechnologies Corporation$40K
Janssen Research & Development, LLC$30K

What the payments were for

Consulting fees$97,40169%
Speaking & faculty fees$21,04915%
Travel & lodging$19,10214%
Food & beverage$3,5222%
Education$2690%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	16	$37,056
Janssen Scientific Affairs, LLC	7	$26,246
Johnson & Johnson	28	$20,223
Legend Biotech USA Inc.	12	$19,902
Bristol Myers Squibb	15	$16,331
AstraZeneca	4	$5,045
Astrazeneca UK Limited	3	$4,980
Pfizer	6	$4,634
Gilead(2 entities)	3	$4,479
Janssen Global Services, LLC	2	$1,898
Sanofi	2	$196
Novartis	1	$100
Astellas Pharma US Inc	1	$95
Sanofi-aventis U.S. LLC	1	$68
Eisai Inc.	2	$39
AbbVie	1	$26
Regeneron	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CARVYKTI$23,357
ABECMA$15,501
RYBREVANT$6,473
CALQUENCE$2,460
TECVAYLI$2,019
DARZALEX$508
Pomalyst$300
TALVEY$264
KYMRIAH$100

How this compares

$141,343 in reported general payments places this provider in the 90th percentile of 79 hematology providers in Florida.

See all hematology providers in Florida →

Medicare billing

Part B allowed, 2024

$22,667

Medicare patients

Services billed

248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sirolimus	11	$2,981
Acyclovir	43	$914
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	20	$103
Oxycodone Hcl	17	$100
Zolpidem Tartrate	11	$58

Paid to pharmacies, not to this prescriber.

Other hematology in Tampa

Javier Pinilla-IbarzTampa$1.6M
Rami KomrokjiTampa$855K
Melissa AlsinaTampa$64K
Alan ListTampa$49K
Michael JainTampa$48K
Lubomir SokolTampa$19K
Kamran DarabiTampa$6K
Lia PerezTampa$3K
Nima GhalehsariTampa$3K
Elizabeth SagatysTampa$2K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →